Reports for IRBESARTAN
Ingredient
IRBESARTAN
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
AVAPRO | 150MG | TABLET | Resolved | 2022-01-21 | 2022-06-09 | 153358 |
AVAPRO | 300MG | TABLET | Resolved | 2019-02-08 | 2019-03-29 | 75171 |
AVAPRO | 300MG | TABLET | Resolved | 2019-07-16 | 2019-11-05 | 89476 |
AVAPRO | 300MG | TABLET | Resolved | 2019-11-29 | 2020-01-24 | 100061 |
AVAPRO | 300MG | TABLET | Resolved | 2020-03-12 | 2020-04-22 | 108533 |
AVAPRO | 300MG | TABLET | Resolved | 2021-12-02 | 2022-06-09 | 150376 |
AVAPRO | 300MG | TABLET | Resolved | 2022-08-02 | 2022-09-17 | 165911 |
AVALIDE | 12.5MG 150MG | TABLET | Resolved | 2018-12-20 | 2019-02-27 | 70230 |
AVALIDE | 12.5MG 150MG | TABLET | Resolved | 2019-10-09 | 2020-01-24 | 95800 |
AVALIDE | 150MG 12.5MG | TABLET | Resolved | 2021-01-28 | 2021-03-20 | 132678 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MYLAN-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-04-04 | 2018-08-11 | 44867 |
MYLAN-IRBESARTAN | 300MG | TABLET | Discontinued | 2017-08-24 | 2017-10-03 | 20271 |
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |